These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15306248

  • 41. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH.
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [Abstract] [Full Text] [Related]

  • 42. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S, Moon M, Park S.
    J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
    [Abstract] [Full Text] [Related]

  • 43. Neurotoxicity of MPTP to migrating neuroblasts: studies in acute and subacute mouse models of Parkinson's disease.
    He XJ, Yamauchi H, Uetsuka K, Nakayama H.
    Neurotoxicology; 2008 May; 29(3):413-20. PubMed ID: 18387672
    [Abstract] [Full Text] [Related]

  • 44. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J, Wang YY, Liu L, Wang QD, Yuan ZY, Zhang ZX, Gu P, Wang MW.
    Neurosci Lett; 2008 Dec 26; 448(2):184-8. PubMed ID: 18977411
    [Abstract] [Full Text] [Related]

  • 45. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice.
    Chalimoniuk M, Langfort J.
    Neurochem Int; 2007 May 26; 50(6):821-33. PubMed ID: 17379358
    [Abstract] [Full Text] [Related]

  • 46. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ, Hebert G, Lin LY, Luo YL, Moze E, Li KS, Neveu PJ.
    J Neuroimmunol; 2005 Jan 26; 158(1-2):14-25. PubMed ID: 15589033
    [Abstract] [Full Text] [Related]

  • 47. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb 26; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 48. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
    Shepherd KR, Lee ES, Schmued L, Jiao Y, Ali SF, Oriaku ET, Lamango NS, Soliman KF, Charlton CG.
    Pharmacol Biochem Behav; 2006 Mar 26; 83(3):349-59. PubMed ID: 16580056
    [Abstract] [Full Text] [Related]

  • 49. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys.
    Vázquez-Claverie M, Garrido-Gil P, San Sebastián W, Belzunegui S, Izal-Azcárate A, López B, Marcilla I, Luquin MR.
    J Neuropathol Exp Neurol; 2009 Jan 26; 68(1):26-36. PubMed ID: 19104449
    [Abstract] [Full Text] [Related]

  • 50. (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice.
    Chan P, Di Monte DA, Langston JW, Janson AM.
    J Pharmacol Exp Ther; 1997 Jan 26; 280(1):439-46. PubMed ID: 8996226
    [Abstract] [Full Text] [Related]

  • 51. Microarray analysis of laser capture microdissected substantia nigra pars compacta after a single administration of MPTP in common marmosets.
    Iwata S, Nomoto M, Miyata A.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Aug 26; 27(4):161-6. PubMed ID: 17879594
    [Abstract] [Full Text] [Related]

  • 52. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
    O'Callaghan JP, Martin PM, Mass MJ.
    Ann N Y Acad Sci; 1998 May 30; 844():40-9. PubMed ID: 9668663
    [Abstract] [Full Text] [Related]

  • 53. FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.
    Otto D, Unsicker K.
    Glia; 1994 May 30; 11(1):47-56. PubMed ID: 8070894
    [Abstract] [Full Text] [Related]

  • 54. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S, Morissette M, Morin N, Di Paolo T.
    J Neuroendocrinol; 2005 Aug 30; 17(8):509-17. PubMed ID: 16011487
    [Abstract] [Full Text] [Related]

  • 55. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
    Xu CL, Qu R, Zhang J, Li LF, Ma SP.
    Fitoterapia; 2013 Oct 30; 90():112-8. PubMed ID: 23876367
    [Abstract] [Full Text] [Related]

  • 56. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C, Vaglini F, Pardini C, Caramelli A, Corsini GU.
    Neuropharmacology; 2009 Jun 30; 56(8):1075-81. PubMed ID: 19298832
    [Abstract] [Full Text] [Related]

  • 57. Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity.
    Liang Y, Li S, Guo Q, Zhang Y, Wen C, Zou Q, Su B.
    Brain Res; 2007 Oct 31; 1178():132-40. PubMed ID: 17900537
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Influence of age and gender on cytokine expression in a murine model of Parkinson's disease.
    Ciesielska A, Joniec I, Kurkowska-Jastrzebska I, Przybyłkowski A, Gromadzka G, Członkowska A, Członkowski A.
    Neuroimmunomodulation; 2007 Oct 31; 14(5):255-65. PubMed ID: 18196934
    [Abstract] [Full Text] [Related]

  • 60. [Effect of the oil from ganoderma lucidum spores on pathological changes in the substantia nigra and behaviors of MPTP-treated mice].
    Zhu WW, Liu ZL, Xu HW, Chu WZ, Ye QY, Xie AM, Chen L, Li JR.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun 31; 25(6):667-71. PubMed ID: 15958304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.